Author Topic: FDA warning on gadolinium contrast agents  (Read 149 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
FDA panel backs new warning for gadolinium contrast agents
« on: September 12, 2017, 03:17:36 pm »
An FDA advisory panel has voted to include a warning label on gadolinium contrast agents, with which persons with MS are undoubtedly familiar because they are used routinely with most MRIs.

From MedPage Today, September 11, 2017:

https://www.medpagetoday.com/Radiology/DiagnosticRadiology/67811?xid=nl_mpt_DHE_2017-09-12&eun=g345846d0r&pos=0
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
96 Views
Last post March 30, 2018, 07:14:31 pm
by agate
0 Replies
65 Views
Last post July 13, 2018, 04:29:42 pm
by agate
0 Replies
89 Views
Last post March 17, 2019, 11:18:38 am
by agate
0 Replies
18 Views
Last post January 13, 2023, 09:11:48 pm
by agate
0 Replies
15 Views
Last post December 13, 2023, 09:11:22 pm
by agate